UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials

Stroke (1970), 2017-07, Vol.48 (7), p.2007-2012

2017

Volltextzugriff (PDF)

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

The New England journal of medicine, 2019-11, Vol.381 (22), p.2103-2113

2019

Volltextzugriff (PDF)

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

The New England journal of medicine, 2018-07, Vol.379 (3), p.215-225

2018

Volltextzugriff (PDF)

Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial

Lancet neurology, 2016-10, Vol.15 (11), p.1160-1169

2016

Volltextzugriff (PDF)

Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials

JAMA neurology, 2019-12, Vol.76 (12), p.1466

2019

Volltextzugriff (PDF)

Levetiracetam no better than phenytoin in children with convulsive status epilepticus

The Lancet (British edition), 2019-05, Vol.393 (10186), p.2101-2102

2019

Volltextzugriff (PDF)

Mapping acute lesion locations to physiological swallow impairments after stroke

NeuroImage clinical, 2019-01, Vol.22, p.101685-101685, Article 101685

2019

Volltextzugriff (PDF)

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale

Stroke (1970), 2015-08, Vol.46 (8), p.2238-2243

2015

Volltextzugriff (PDF)

Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial

Neurology, 2018-12, Vol.91 (23), p.e2163

2018

Volltextzugriff (PDF)

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease

PloS one, 2015-07, Vol.10 (7), p.e0133002-e0133002

2015

Volltextzugriff (PDF)

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial

Circulation (New York, N.Y.), 2019-08, Vol.140 (8), p.658-664

2019

Volltextzugriff (PDF)

Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage

Annals of neurology, 2017-11, Vol.82 (5), p.755-765

2017

Volltextzugriff (PDF)

Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial

Epilepsia (Copenhagen), 2021-03, Vol.62 (3), p.795-806

2021

Volltextzugriff (PDF)

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial

Movement disorders, 2016-05, Vol.31 (5), p.709-714

2016

Volltextzugriff (PDF)

Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus

Journal of clinical epidemiology, 2013-08, Vol.66 (8), p.S130-S137

2013

Volltextzugriff (PDF)

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke

Circulation (New York, N.Y.), 2019-08, Vol.140 (8), p.658-664

2019

Volltextzugriff (PDF)

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

Lancet neurology, 2015-08, Vol.14 (8), p.795-803

Anon

2015

Volltextzugriff (PDF)

Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis

Stroke (1970), 2018-06, Vol.49 (6), p.1457-1463

2018

Volltextzugriff (PDF)

Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial

JAMA neurology, 2019-07, Vol.76 (7), p.774

2019

Volltextzugriff (PDF)

Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities

Stroke (1970), 2021-10, Vol.52 (10), p.e635-e645

2021

Volltextzugriff (PDF)

Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial

Stroke (1970), 2020-03, Vol.51 (3), p.792-799

2020

Volltextzugriff (PDF)

Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status Epilepticus

Journal of clinical neurophysiology, 2022-09, Vol.39 (6), p.441-445

2022

Volltextzugriff (PDF)

A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial

Contemporary clinical trials, 2019-11, Vol.86, p.105852-105852, Article 105852

2019

Volltextzugriff (PDF)

Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform

Stroke (1970), 2024-09, Vol.55 (9), p.2397-2400

2024

Volltextzugriff (PDF)

Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial

Stroke (1970), 2020-07, Vol.51 (7), p.2058-2065

2020

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(141)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial

Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials

Levetiracetam no better than phenytoin in children with convulsive status epilepticus

Mapping acute lesion locations to physiological swallow impairments after stroke

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale

Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial

Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage

Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial

Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis

Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial

Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities

Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial

Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status Epilepticus

A pragmatic, adaptive clinical trial design for a rare disease: The FOcal Cerebral Arteriopathy Steroid (FOCAS) trial

Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform

Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial

Suchergebnisse filtern